comparemela.com

Clear Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CLEAR Trial: Lenvatinib plus Pembrolizumab in Advanced RCC

Experts highlight key clinical updates from the CLEAR trial presented at the 2023 IKCS: North America congress, assessing lenvatinib plus pembrolizumab in patients with advanced RCC.

United statesSurrounding meetingsNorth americaRenal cell carcinomaAdvanced renal cell carcinomaAdvanced rccRenal cell carcinoma treatmentsRcc treatmentsClear trialClear studyAdvanced rcc treatmentAdvanced renal cell carcinoma treatment

Advanced RCC: Safety and Efficacy of IO/TKI Combination Therapies

Genitourinary oncologists discuss the safety and efficacy of IO/TKI and IO/IO combination therapies in advanced renal cell carcinoma.

Advanced kidney cancer treatment landscapeKidney cancerRenal cell carcinomaKidney cancer studiesKidney cancer trialsClear trialKeynote 426Checkmate 9er

Patient Profile: A 67-Year-Old Man With Metastatic Clear Cell RCC

Benjamin Garmezy, MD, presents the case of a 67-year-old man diagnosed with advanced renal cell carcinoma.

Pedro barataBenjamin garmezyRenal cell carcinomaMetastatic clear cell rccImdc intermediate riskImdc risk scoreDoublet immunotherapyIo tkisClear trial

Front Line Trials in Advanced RCC

Renal cell carcinoma experts discuss clinical trials, evaluating immunotherapies and tyrosine kinase inhibitors in the front line setting of advanced RCC.

Benjamin garmezyPedro barataRenal cell carcinomaClear trialCheckmate 9erKeynote 426Checkmate 214Io tkis

vimarsana © 2020. All Rights Reserved.